Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

5.6K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.6K
Peroxisomes01:24

Peroxisomes

22.1K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
22.1K
Peroxisomes01:24

Peroxisomes

1.9K
1.9K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

335
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

304
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
304

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PEX14 acts as a molecular link between optineurin and the autophagic machinery to induce pexophagy.

The Journal of cell biology·2025
Same author

Peroxisomal metabolism of branched fatty acids regulates energy homeostasis.

Nature·2025
Same author

Identification of a novel <i>PEX14</i> mutation in Zellweger syndrome.

BMJ case reports·2025
Same author

HSD17B4 deficiency causes dysregulation of primary cilia and is alleviated by acetyl-CoA.

Nature communications·2025
Same author

Author Correction: Oligodendroglial fatty acid metabolism as a central nervous system energy reserve.

Nature neuroscience·2024
Same author

Oligodendroglial fatty acid metabolism as a central nervous system energy reserve.

Nature neuroscience·2024

Related Experiment Video

Updated: Apr 1, 2026

Monitoring Stub1-Mediated Pexophagy
08:26

Monitoring Stub1-Mediated Pexophagy

Published on: May 12, 2023

2.2K

Hepatic dysfunction in peroxisomal disorders.

Myriam Baes1, Paul P Van Veldhoven2

  • 1Laboratory for Cell Metabolism, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, B-3000 Leuven, Belgium.

Biochimica Et Biophysica Acta
|October 11, 2015
PubMed
Summary
This summary is machine-generated.

Peroxisomal disorders disrupt essential liver metabolism, causing hepatic pathology. Understanding these defects, including enzyme import and substrate transport issues, is crucial for disease management.

More Related Videos

Measurement of Fatty Acid &#946;-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.6K
Peroxisome Staining in Mammalian Cells Using Peroxisome-Specific Probes
05:57

Peroxisome Staining in Mammalian Cells Using Peroxisome-Specific Probes

Published on: December 19, 2025

577

Related Experiment Videos

Last Updated: Apr 1, 2026

Monitoring Stub1-Mediated Pexophagy
08:26

Monitoring Stub1-Mediated Pexophagy

Published on: May 12, 2023

2.2K
Measurement of Fatty Acid &#946;-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes
11:03

Measurement of Fatty Acid β-Oxidation in a Suspension of Freshly Isolated Mouse Hepatocytes

Published on: September 9, 2021

4.6K
Peroxisome Staining in Mammalian Cells Using Peroxisome-Specific Probes
05:57

Peroxisome Staining in Mammalian Cells Using Peroxisome-Specific Probes

Published on: December 19, 2025

577

Area of Science:

  • Cell Biology
  • Biochemistry
  • Genetics

Background:

  • Peroxisomes in hepatocytes are vital for metabolic conversions.
  • Defects in peroxisomal disorders arise from enzyme import failures or mutations in enzymes/transporters.
  • Hepatic pathology is a key feature of peroxisome biogenesis and beta-oxidation disorders.

Purpose of the Study:

  • To review the impact of peroxisome malfunction on hepatic pathology and cellular compartments.
  • To examine affected metabolic pathways, including bile acid formation and fatty acid degradation.
  • To clarify the relationship between deregulated metabolites and pathological events in peroxisomal disorders.

Main Methods:

  • Literature review of peroxisomal disorders and their hepatic manifestations.
  • Analysis of metabolic pathways affected by peroxisome dysfunction.
  • Comparison of human phenotypes with mouse models to identify discrepancies.

Main Results:

  • Peroxisome malfunction impacts hepatocytes, mitochondria, and the endoplasmic reticulum.
  • Key metabolic pathways like bile acid formation and fatty acid degradation are affected.
  • Mouse models show liver pathologies, but concordance with human phenotypes varies due to factors like diet and enzyme expression.

Conclusions:

  • Peroxisomal disorders lead to significant hepatic pathology and metabolic dysregulation.
  • The precise link between altered metabolites and disease progression requires further investigation.
  • Understanding these complex interactions is essential for developing therapeutic strategies.